Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008

Published:2011-09-29 Issue:10 Volume:21 Page:1036-1044
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Timmers Lonneke¹,Beckeringh Jan Jacob²,van Herk-Sukel Myrthe P. P.³,Boven Epie⁴,Hugtenburg Jacqueline G.

Affiliation:

1. Department of Clinical Pharmacology and Pharmacy; VU University Medical Center; Amsterdam; The Netherlands

2. Health Care Insurance Board (CVZ); Diemen; The Netherlands

3. PHARMO Institute for Drug Outcomes Research; Utrecht; The Netherlands

4. Department of Medical Oncology; VU University Medical Center; Amsterdam; The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference42 articles.

1. Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/ leucovorin in patients with colorectal cancer;Pfeiffer;Eur J Cancer,2006

2. A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer;Twelves;Ann Oncol,2006

3. Effective oral chemotherapy for breast cancer: pillars of strength;Findlay;Ann Oncol,2008

4. Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness;Twelves;Clin Colorectal Cancer,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States;Leukemia & Lymphoma;2021-11-15

2. Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs;Anticancer Research;2021-11

3. Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study;Canadian Journal of Public Health;2021-01-20

4. Survey of serious adverse events and safety evaluation of oral anticancer drug treatment in Japan: A retrospective study;Molecular and Clinical Oncology;2020-11-25

5. Real-life adherence in capecitabine therapy using two analysis methods and persistence after 6 months of treatment;Journal of Oncology Pharmacy Practice;2020-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3